Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06979557 · ClinicalTrials.gov registry record
RLE Outcomes With Bilateral Implantation of Odyssey IOLs
A clinical trial of Refractive Lens Exchange, sponsored by Mann Eye Institute.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06979557 is a study of Refractive Lens Exchange that has completed, run by Mann Eye Institute. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06979557, a study of Refractive Lens Exchange, has completed, sponsored by Mann Eye Institute.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as measurement of visual acuities at distance, intermediate, and near, monocular (right eye) and binocular defocus curve, and refractive outcomes.
Conditions Studied
Interventions
- DEVICE Odyssey IOL
Study Locations (1)
Texas
- Mann Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-07-21 |
| Est. Completion | 2026-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06979557
The ClinicalTrials.gov registry entry for NCT06979557 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mann Eye Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Refractive Lens Exchange appearing as the primary indexed condition, and to 1 intervention - of which Odyssey IOL is the first listed.
NCT06979557 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06979557 about?
NCT06979557 is a clinical study titled "RLE Outcomes With Bilateral Implantation of Odyssey IOLs". This study is a single center, ambispective study of visual outcomes after successful bilateral implantation of the Odyssey IOL. Subjects will be assessed at least 2 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS questionnaire, as well as mea...
What is the current status of trial NCT06979557?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2025-07-21. Estimated completion is 2026-01-01.
What conditions does trial NCT06979557 study?
This clinical trial studies the following conditions: Refractive Lens Exchange.
What interventions are being tested in trial NCT06979557?
The interventions under investigation include: Odyssey IOL (DEVICE).
Who is sponsoring clinical trial NCT06979557?
This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06979557 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.